tiprankstipranks
LENZ Therapeutics (LENZ)
NASDAQ:LENZ
US Market
LENZ
LENZ Therapeutics
RESEARCH TOOLSreports

LENZ Therapeutics (LENZ) Financial Statements

Compare
368 Followers

LENZ Therapeutics Financial Overview

LENZ Therapeutics's market cap is currently $280.31M. The company's EPS TTM is $-1.16; its P/E ratio is -5.61; LENZ Therapeutics is scheduled to report earnings on March 25, 2026, and the estimated EPS forecast is $-1.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 19.09M$ 0.00$ 0.00$ 15.00M$ 0.00
Gross Profit$ 18.67M$ -58.00K$ 0.00$ 15.00M$ -734.00K
Operating Income$ -91.14M$ -58.61M$ -72.43M$ -10.48M$ -60.44M
EBITDA$ -91.14M$ -49.71M$ -72.41M$ -10.47M$ -70.03M
Net Income$ -82.13M$ -49.77M$ -69.97M$ -10.81M$ -70.76M
Balance Sheet
Cash & Short-Term Investments$ 292.35M$ 209.03M$ 65.79M$ 44.44M$ 18.31M
Total Assets$ 305.88M$ 215.30M$ 70.38M$ 46.95M$ 18.34M
Total Debt$ 350.00K$ 1.38M$ 329.00K$ 250.00K$ 0.00
Net Debt$ -24.83M$ -18.78M$ -34.81M$ -44.19M$ -18.31M
Total Liabilities$ 21.54M$ 11.22M$ 163.09M$ 71.12M$ 32.55M
Stockholders' Equity$ 284.34M$ 204.08M$ -92.71M$ -24.17M$ -14.21M
Cash Flow
Free Cash Flow$ -70.00M$ -59.86M$ -60.41M$ -94.57M$ -58.59M
Operating Cash Flow$ -69.17M$ -59.39M$ -60.38M$ -87.98M$ -52.85M
Investing Cash Flow$ -75.67M$ -154.48M$ -29.62M$ -241.86M$ -5.74M
Financing Cash Flow$ 149.75M$ 199.00M$ 80.70M$ 597.00K$ 417.47M
Currency in USD

LENZ Therapeutics Earnings and Revenue History

Income Statement >

LENZ Therapeutics Debt to Assets

Balance Sheet >

LENZ Therapeutics Cash Flow

Cash Flow >

LENZ Therapeutics Forecast EPS vs Actual EPS

Earnings >